Richard Kellermayer, MD, PhD, presents Microbiome 101: Could Fecal Microbiota Transplants (FMT) Play a Role in Inflammatory Bowel Disease? as part of the 2022 Specific Carbohydrate Diet Association (SCDA) Speaker Series.
In this educational presentation, Dr. Kellermayer introduces foundational concepts related to the microbiome, including microbes, microbiota, and microbial balance, and explores the scientific rationale behind fecal microbiota transplantation (FMT) as a microbial-based therapeutic approach. The discussion focuses on current research and emerging understanding of how microbial therapies may relate to IBD, including Crohn’s disease and ulcerative colitis.
Video objectives include:
Understanding microbes, microbiota, and the microbiome
Overview of fecal microbiota transplantation (FMT)
Dysbiosis and disease-specific microbial patterns in IBD
Considerations around microbial-based therapies
Dr. Kellermayer is the Director of the Pediatric Inflammatory Bowel Disease Program at Texas Children’s Hospital and Baylor College of Medicine. He is a pediatric gastroenterologist with special expertise in IBD, Clostridium difficile infection, and microbiome-focused research. He also serves as the Medical Director of the Fecal Microbiota Transplantation (FMT) Program at Texas Children’s Hospital.